1-(3-BROMO-5-CHLOROPYRIDIN-2-YL)ETHANAMINE HCL, 95.0%, 1g

N-((11bS)-2,6-Bis(4-(naphthalen-2-yl)phenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide, 98%, 100mg

N'-[1-Amino-2-(3,5-bis-(trifluoromethyl)phenyl)ethylidene]hydrazine carboxylic acid tert-butyl, 95.0%, 1g

(S)-3-(2,2-dimethyl-1,3-dioxolan-4-yl)propan-1-ol, 95%, 100mg

6-(2,5-DIMETHYLPHENOXY)HEXAN-1-OL, 95.0%, 1g

Sodium 3,4-dioxo-3,4-dihydronaphthalene-1-sulfonate, 97.0%, 10g

Benzyl N-(4-bromo-2-fluorophenyl)carbamate, 98%, 5g

Methyl 3-Iodo-4-methylbenzoate>98.0%(GC)25g

2-Phenyloxazole, 95.0%, 100mg

2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 250mg

Plat ROTILABO®, 0,5 l, 230 mm, 1 pièce

(2E)-1-(2,5-dimethoxyphenyl)-3-phenylprop-2-en-1-one, 95.0%, 2g

(R)-Methyl 2-amino-3-((tert-butoxycarbonyl)amino)propanoate, 95.0%, 5g